Search

everythinglearnresearchcommunity

for

Search:↓

Nutrafol might help reduce hair loss due to inflammation, but more evidence is needed.

Antiandrogens and finasteride may help treat excess hair and hair loss in women.

AKR1C enzymes in scalp glands decrease with age, possibly affecting hair loss.

New treatments for androgenetic alopecia show promise but need more research for validation.

Combination therapies for androgenetic alopecia are more effective, but more research is needed for safe, standardized treatments.

Androgenetic alopecia in men is genetic and linked to health issues like obesity and heart disease, with treatments including minoxidil, finasteride, and hair transplants.

Scientists created cell lines from balding patients and found that cells from the front of the scalp are more affected by hormones that cause hair loss than those from the back.

Male pattern hair loss may be linked to the developmental origins of hair follicles.

The research identified genes and non-coding RNAs in cells that could be affected by testosterone, which may help understand hair loss and prostate cancer.

Androgenetic alopecia, a common hair loss condition, can be treated with topical minoxidil, oral finasteride, or oral spironolactone, and new treatments like platelet-rich plasma, low-level laser therapy, and janus-kinase inhibitors are being explored.

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.

There is no strong evidence that chemopreventive agents effectively prevent prostate cancer.

New treatments targeting insulin, blood flow, and inflammation could improve hormone-related hair conditions with fewer side effects.

Alopecia areata, a type of hair loss, may be passed through T cells and has genetic links, while treatments vary in effectiveness. Male pattern baldness can be treated with finasteride and is influenced by androgens in hair follicles.

Testosterone plays a big role in heart and nervous system damage caused by inflammation in male rats, suggesting that blocking testosterone production could help manage this condition.

Mutations in the AR gene cause hair thinning and loss.

COVID-19 severely affects older adults with chronic heart, lung, or metabolic diseases.

The animal models successfully simulated dry eye related to sex steroid deficiency.

Men are more at risk for severe COVID-19 due to biological differences, suggesting the need for targeted treatments.

Erlotinib can cause significant but temporary hair loss in lung cancer patients.

Hair loss in men may be caused by inflammation triggered by hormones, and treatments reducing inflammation could potentially promote hair growth.

Balding hair follicles have less growth-promoting factors and more inhibitory factors, leading to hair loss.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

The research suggests immune system changes and specific gene expression may contribute to male hair loss, proposing potential new treatments.

Chemotherapy often causes skin and hair issues, but early management can help improve patient care.

Testosterone replacement therapy helps manage deficiency and has various methods, but requires careful monitoring to avoid side effects.

Bicalutamide may help treat female pattern hair loss.

Finasteride helps treat hair loss by blocking enzyme activity.

Understanding EGFR roles could lead to new hair loss treatments.

Manipulating EGFR signaling may help treat hair loss and promote hair growth.